Annual report [Section 13 and 15(d), not S-K Item 405]

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit)

v3.25.0.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Previously Reported [Member]
Revision of Prior Period, Adjustment [Member]
Common Stock
Common Stock
Revision of Prior Period, Adjustment [Member]
Additional Paid-in Capital
 [1]
Additional Paid-in Capital
Revision of Prior Period, Adjustment [Member]
 [1]
AOCI Attributable to Parent
AOCI Attributable to Parent
Revision of Prior Period, Adjustment [Member]
Accumulated Deficit
Accumulated Deficit
Revision of Prior Period, Adjustment [Member]
Restatement Adjustment     $ (9,430)           $ 50   $ (9,480)
Beginning balance at Dec. 31, 2021 $ 190,207 $ 732 180,777 $ 2 [1] $ 2 [1] $ 438,709 $ 438,709   782 $ (249,236) (258,716)
Beginning balance, shares at Dec. 31, 2021 [1]       18,894,262 18,894,262            
Beginning balance at Dec. 31, 2021 190,207 732 180,777 $ 2 [1] $ 2 [1] 438,709 438,709   782 (249,236) (258,716)
Beginning balance, shares at Dec. 31, 2021 [1]       18,894,262 18,894,262            
Beginning balance at Dec. 31, 2021 190,207 732 180,777 $ 2 [1] $ 2 [1] 438,709 438,709   782 (249,236) (258,716)
Beginning balance, shares at Dec. 31, 2021 [1]       18,894,262 18,894,262            
Beginning balance at Dec. 31, 2021 190,207 732 180,777 $ 2 [1] $ 2 [1] 438,709 $ 438,709   $ 782 (249,236) $ (258,716)
Beginning balance, shares at Dec. 31, 2021 [1]       18,894,262 18,894,262            
Exercise of stock options 806         806          
Exercise of stock options, shares [1]       62,975              
Conversion of warrants to common stock 4,206         4,206          
Conversion of warrants to common stock, Share [1]       413,910              
Net Income (Loss) (99,012) (89,411) (9,601)             (99,012)  
Foreign currency translation adjustments (7,657) (7,696) [2] 39 [2]         $ (7,657)      
Release of Restricted Stock Units (70)         (70)          
Release of Restricted Stock Units, Shares [1]       30,310              
Issuance of common stock upon ESPP purchase, shares [1]       65,726              
Stock compensation expense 11,491         11,491          
Issuance of common stock upon ESPP purchase 623         623          
Net unrealized gain (loss) on investments (net of tax) (33)             (33)      
Ending balance at Dec. 31, 2022 91,131 110,123 (18,992) $ 2 [1]   455,765   (6,908)   (357,728)  
Ending balance, shares at Dec. 31, 2022 [1]       19,467,183              
Ending balance at Dec. 31, 2022 91,131 110,123 (18,992) $ 2 [1]   455,765   (6,908)   (357,728)  
Ending balance, shares at Dec. 31, 2022 [1]       19,467,183              
Beginning balance at Dec. 31, 2022 91,131 110,123 (18,992) $ 2 [1]   455,765   (6,908)   (357,728)  
Beginning balance, shares at Dec. 31, 2022 [1]       19,467,183              
Beginning balance at Dec. 31, 2022 91,131 110,123 (18,992) $ 2 [1]   455,765   (6,908)   (357,728)  
Beginning balance, shares at Dec. 31, 2022 [1]       19,467,183              
Beginning balance at Dec. 31, 2022 91,131 110,123 (18,992) $ 2 [1]   $ 455,765   (6,908)   (357,728)  
Beginning balance, shares at Dec. 31, 2022 [1]       19,467,183              
Exercise of stock options $ 3                    
Exercise of stock options, shares 500     500 [1]   3          
Conversion of warrants to common stock $ 286         $ 286          
Conversion of warrants to common stock, Share [1]       34,728              
Redemption of fractional shares due to reverse stock split, Shares [1]       (47)              
Redemption of fractional shares due to reverse stock split (1)         (1)          
Net Income (Loss) (77,558) (63,956) (13,602)             (77,558)  
Foreign currency translation adjustments 2,318   (160) [2]         2,318      
Release of Restricted Stock Units, Shares [1]       781,557              
Issuance of common stock under the Equity Distribution Agreement, net (Shares) [1]       2,166,384              
Issuance of common stock under the Equity Distribution Agreement, net 7,866         7,866          
Issuance of common stock upon ESPP purchase, shares [1]       154,371              
Stock compensation expense 12,978         12,978          
Issuance of common stock upon ESPP purchase 727         727          
Net unrealized gain (loss) on investments (net of tax) 34             34      
Ending balance at Dec. 31, 2023 37,784 70,538 (32,754) $ 2 [1]   477,624   (4,556)   (435,286)  
Ending balance, shares at Dec. 31, 2023 [1]       22,604,676              
Ending balance at Dec. 31, 2023 $ 37,784 $ 70,538 $ (32,754) $ 2 [1]   $ 477,624   $ (4,556)   $ (435,286)  
Ending balance, shares at Dec. 31, 2023 [1]       22,604,676              
[1] The shares of the Company's common stock have been retroactively adjusted to reflect the 1-for-8 reverse stock split (Note 1)
[2] The $160 foreign currency translation loss and $39 foreign currency translation gain for the years ended December 31, 2023 and December 31, 2022, respectively, are related to the foreign currency translation impact of consolidated statements of operations adjustments (i) to (v) above.